HEADER VIRAL PROTEIN 26-AUG-21 7PKU TITLE STRUCTURE OF SARS-COV-2 NUCLEOPROTEIN IN DYNAMIC COMPLEX WITH ITS TITLE 2 VIRAL PARTNER NSP3A COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GROWTH FACTOR-LIKE PEPTIDE,LEADER PROTEIN,NON-STRUCTURAL COMPND 5 PROTEIN 10,NON-STRUCTURAL PROTEIN 2,NON-STRUCTURAL PROTEIN 3,NON- COMPND 6 STRUCTURAL PROTEIN 4,NON-STRUCTURAL PROTEIN 6,NON-STRUCTURAL PROTEIN COMPND 7 7,NON-STRUCTURAL PROTEIN 8,NON-STRUCTURAL PROTEIN 9,PAPAIN-LIKE COMPND 8 PROTEINASE,P65 HOMOLOG; COMPND 9 EC: 3.4.19.12,3.4.22.69; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: NUCLEOPROTEIN; COMPND 13 CHAIN: B; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: ORF1AB; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 11 2; SOURCE 12 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 13 ORGANISM_TAXID: 2697049; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SARS-COV-2; NUCLEOPROTEIN; NSP3; NMR; INTRINSICALLY DISORDERED KEYWDS 2 PROTEIN; CHAPERONE; REPLICATION; NUCLEOCAPSID; RNA; SAXS, VIRAL KEYWDS 3 PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR L.M.BESSA,S.GUSEVA,A.R.CAMACHO-ZARCO,N.SALVI,M.BLACKLEDGE REVDAT 3 14-JUN-23 7PKU 1 REMARK REVDAT 2 02-FEB-22 7PKU 1 JRNL REVDAT 1 19-JAN-22 7PKU 0 JRNL AUTH L.M.BESSA,S.GUSEVA,A.R.CAMACHO-ZARCO,N.SALVI,D.MAURIN, JRNL AUTH 2 L.M.PEREZ,M.BOTOVA,A.MALKI,M.NANAO,M.R.JENSEN,R.W.H.RUIGROK, JRNL AUTH 3 M.BLACKLEDGE JRNL TITL THE INTRINSICALLY DISORDERED SARS-COV-2 NUCLEOPROTEIN IN JRNL TITL 2 DYNAMIC COMPLEX WITH ITS VIRAL PARTNER NSP3A. JRNL REF SCI ADV V. 8 M4034 2022 JRNL REFN ESSN 2375-2548 JRNL PMID 35044811 JRNL DOI 10.1126/SCIADV.ABM4034 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7PKU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1292117877. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298; 298; 298; 298; 298; REMARK 210 298 REMARK 210 PH : 6.5; 6.5; 6.5; 6.5; 6.5; 6.5; REMARK 210 6.5 REMARK 210 IONIC STRENGTH : 250; 250; 250; 250; 250; 250; REMARK 210 250 REMARK 210 PRESSURE : 1 ATM; 1 ATM; 1 ATM; 1 ATM; 1 REMARK 210 ATM; 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 500 UM [U-15N] SN3, 550 UM REMARK 210 SUBL1, 50 MM SODIUM PHOSPHATE, REMARK 210 250 MM SODIUM CHLORIDE, 2 MM DTT, REMARK 210 90% H2O/10% D2O; 500 UM SN3, REMARK 210 550 UM SUBL1, 50 MM SODIUM REMARK 210 PHOSPHATE, 250 MM SODIUM REMARK 210 CHLORIDE, 2 MM DTT, 90% H2O/10% REMARK 210 D2O; 500 UM [U-15N] SUBL1, 550 REMARK 210 UM SN3, 50 MM SODIUM PHOSPHATE, REMARK 210 250 MM SODIUM CHLORIDE, 2 MM DTT, REMARK 210 90% H2O/10% D2O; 500 UM [U-13C; REMARK 210 U-15N] SN3, 550 UM SUBL1, 50 MM REMARK 210 SODIUM PHOSPHATE, 250 MM SODIUM REMARK 210 CHLORIDE, 2 MM DTT, 90% H2O/10% REMARK 210 D2O; 500 UM [U-13C; U-15N] REMARK 210 SN3(S235F), 550 UM SUBL1, 50 MM REMARK 210 SODIUM PHOSPHATE, 250 MM SODIUM REMARK 210 CHLORIDE, 2 MM DTT, 90% H2O/10% REMARK 210 D2O; 500 UM [U-13C; U-15N] SUBL1, REMARK 210 550 UM SN3, 50 MM SODIUM REMARK 210 PHOSPHATE, 250 MM SODIUM REMARK 210 CHLORIDE, 2 MM DTT, 90% H2O/10% REMARK 210 D2O; 500 UM 100% A220I CD1 13C REMARK 210 SUBL1, 550 UM SN3, 50 MM SODIUM REMARK 210 PHOSPHATE, 250 MM SODIUM REMARK 210 CHLORIDE, 2 MM DTT, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; 15N EDITED 3D NOESY-HSQC; REMARK 210 13C EDITED 3D NOESY-HSQC; 13C REMARK 210 EDITED NOESY-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 950 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRFAM-SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 26 -23.04 67.11 REMARK 500 1 ASP A 28 -65.76 -152.82 REMARK 500 1 ILE A 31 12.94 57.44 REMARK 500 1 GLU A 45 -8.82 84.52 REMARK 500 1 PRO A 67 -3.53 -55.93 REMARK 500 1 VAL A 68 -74.24 -90.19 REMARK 500 1 SER A 69 -39.72 66.71 REMARK 500 1 LEU A 79 -3.31 69.29 REMARK 500 1 SER A 93 -54.94 69.09 REMARK 500 1 ASN B 192 -51.01 70.60 REMARK 500 1 ASN B 196 143.61 64.59 REMARK 500 1 SER B 197 124.39 63.03 REMARK 500 1 THR B 205 -46.52 -137.61 REMARK 500 1 MET B 210 -48.70 71.96 REMARK 500 1 ALA B 217 151.60 63.38 REMARK 500 1 LYS B 237 -49.17 70.54 REMARK 500 1 GLN B 244 -41.57 -154.41 REMARK 500 1 VAL B 246 -54.69 -137.82 REMARK 500 1 LYS B 248 -40.44 -135.38 REMARK 500 1 ARG B 262 -49.55 71.28 REMARK 500 2 GLU A 26 -80.61 60.72 REMARK 500 2 LEU A 27 155.69 67.25 REMARK 500 2 GLU A 45 -10.70 85.22 REMARK 500 2 PRO A 67 -8.29 -58.35 REMARK 500 2 SER A 69 -42.58 66.85 REMARK 500 2 GLU A 92 -56.82 -125.73 REMARK 500 2 SER A 93 -48.65 -140.81 REMARK 500 2 SER B 202 -57.92 69.05 REMARK 500 2 ARG B 203 -44.50 -133.11 REMARK 500 2 THR B 205 -44.02 -132.15 REMARK 500 2 ALA B 211 124.04 62.68 REMARK 500 2 GLN B 244 -8.23 -159.31 REMARK 500 2 ARG B 259 -41.70 -133.63 REMARK 500 3 GLU A 26 -74.10 47.62 REMARK 500 3 ASP A 28 -52.70 -156.96 REMARK 500 3 ILE A 31 -1.93 57.28 REMARK 500 3 GLU A 45 -8.04 84.76 REMARK 500 3 VAL A 68 51.14 -117.83 REMARK 500 3 SER A 93 -60.56 67.05 REMARK 500 3 ASP A 110 146.36 63.64 REMARK 500 3 LEU B 219 -35.67 -138.39 REMARK 500 3 LYS B 257 -61.44 103.40 REMARK 500 4 LEU A 27 -51.64 -126.59 REMARK 500 4 ARG A 30 -51.23 -133.67 REMARK 500 4 GLU A 45 -9.47 83.58 REMARK 500 4 GLU A 92 -50.07 -132.79 REMARK 500 4 SER A 93 -44.29 -137.22 REMARK 500 4 PHE A 96 93.35 60.50 REMARK 500 4 ALA B 211 -49.63 70.94 REMARK 500 4 SER B 232 -77.10 -106.05 REMARK 500 REMARK 500 THIS ENTRY HAS 170 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34661 RELATED DB: BMRB REMARK 900 STRUCTURE OF SARS-COV-2 NUCLEOPROTEIN IN DYNAMIC COMPLEX WITH ITS REMARK 900 VIRAL PARTNER NSP3A DBREF1 7PKU A 16 111 UNP A0A6M4N019_SARS2 DBREF2 7PKU A A0A6M4N019 831 926 DBREF1 7PKU B 191 263 UNP A0A6G9KDV1_SARS2 DBREF2 7PKU B A0A6G9KDV1 191 263 SEQRES 1 A 96 GLN GLY TYR LYS SER VAL ASN ILE THR PHE GLU LEU ASP SEQRES 2 A 96 GLU ARG ILE ASP LYS VAL LEU ASN GLU LYS CYS SER ALA SEQRES 3 A 96 TYR THR VAL GLU LEU GLY THR GLU VAL ASN GLU PHE ALA SEQRES 4 A 96 CYS VAL VAL ALA ASP ALA VAL ILE LYS THR LEU GLN PRO SEQRES 5 A 96 VAL SER GLU LEU LEU THR PRO LEU GLY ILE ASP LEU ASP SEQRES 6 A 96 GLU TRP SER MET ALA THR TYR TYR LEU PHE ASP GLU SER SEQRES 7 A 96 GLY GLU PHE LYS LEU ALA SER HIS MET TYR CYS SER PHE SEQRES 8 A 96 TYR PRO PRO ASP GLU SEQRES 1 B 73 ARG ASN SER SER ARG ASN SER THR PRO GLY SER SER ARG SEQRES 2 B 73 GLY THR SER PRO ALA ARG MET ALA GLY ASN GLY GLY ASP SEQRES 3 B 73 ALA ALA LEU ALA LEU LEU LEU LEU ASP ARG LEU ASN GLN SEQRES 4 B 73 LEU GLU SER LYS MET SER GLY LYS GLY GLN GLN GLN GLN SEQRES 5 B 73 GLY GLN THR VAL THR LYS LYS SER ALA ALA GLU ALA SER SEQRES 6 B 73 LYS LYS PRO ARG GLN LYS ARG THR HELIX 1 AA1 ILE A 31 CYS A 39 1 9 HELIX 2 AA2 VAL A 50 LEU A 65 1 16 HELIX 3 AA3 LEU A 71 GLY A 76 1 6 HELIX 4 AA4 ASP A 80 ALA A 85 1 6 HELIX 5 AA5 ALA B 220 GLU B 231 1 12 HELIX 6 AA6 LYS B 248 LYS B 257 1 10 SHEET 1 AA1 4 ALA A 41 VAL A 44 0 SHEET 2 AA1 4 LYS A 19 PHE A 25 -1 N LYS A 19 O VAL A 44 SHEET 3 AA1 4 HIS A 101 SER A 105 1 O CYS A 104 N THR A 24 SHEET 4 AA1 4 TYR A 88 PHE A 90 -1 N PHE A 90 O TYR A 103 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1